VineMeds, Inc Announces Appointment of Ron Krawczyk to Board of Directors
NAPLES, Florida, August 4, 2025 -- VineMeds Inc, a healthcare analytics company revolutionizing pharmaceutical channel management, today announced the appointment of Ron Krawczyk to the VineMeds Board of Director. As a member of the Board of Directors, Mr. Krawczyk will also support the VineMeds senior management team as a Strategic Advisor.
“We are thrilled to add Ron Krawczyk to our Board of Directors, “said David Janca, Founder and Chairman of the Board for VineMeds, Inc. “Over 35 years in the healthcare industry, Mr. Krawczyk has consistently demonstrated his ability to innovate and deliver in the areas of product and business development, sales, marketing, commercial operations and strategy development. I look forward to integrating Mr. Krawczyk’s unique understanding of complex data and his ability to develop and deliver business plans addressing the client’s most unique and difficult business problems with the VineMeds team’s expertise in serialized data and next-generation, AI-driven platform technologies.”
Ron Krawczyk is an internationally recognized thought leader in the areas of pharmaceutical, biotech, biosimilars, generic, and medical device sales and commercial operations. Over Mr. Krawczyk’s 35+ year career in the healthcare industry, he has worked for many top 40 Pharmaceutical, Biotech and Device companies and service providers including Rhone Poulenc, Rhone Poulenc Rorer, Arcola Labs, Centocor, Johnson & Johnson and BlueFin Group, leading projects ranging from product inception and clinical trials all the way through full commercialization, including late-stage product lifecycle extensions.
“I am so pleased to join VineMeds’ Board of Directors and excited for what our future holds, “said Ron Krawczyk. “VineMeds and their seasoned team of experienced technologists and supply chain experts have already established themselves as a true partner to healthcare customers, helping them navigate the complexities of the modern supply chain. By bringing the close relationships and deep ties I’ve developed across the healthcare industry over the last 35 years, I’m confident I can provide the support necessary for the VineMeds team to again transform the meaning of supply chain transparency, optimize product utilization, and redefine channel data aggregation in the healthcare industry.”
In addition to traveling and spending time with his family and friends, Mr. Krawczyk assists with several not-for-profit initiatives and currently serves as the President and Managing Partner of MedEquity Holdings LLC.
​
About VineMeds, Inc
At VineMeds, we're game-changers in pharmaceutical channel management, offering an AI-optimized platform that delivers unprecedented insights and data value. We are your trusted partner in managing legacy EDI data, while also providing a transition path to serialization data; the next generation in supply chain visibility and product optimization. VineMeds can help you eliminate assumptions and ensure no surprises in your operations. Our solutions dramatically increase efficiency, cutting time spent creating analytics by up to 50%. Using powerful AI capabilities, our platform helps you make informed decisions that drive ROI and ultimately improves patient services. We help you manage everything from eliminating returns and overstocks to optimizing pricing and matching supply with demand, all while being guided by industry experts dedicated to your success.
For more information, visit www.vinemeds.com.
Contact: VineMeds, Naples, Florida, 4501 Tamiami Trail N, Suite 226 Naples, FL 34103
Cameron Hall, 716-474-2995 (Media)
Conrad Morgiewicz, 978-549-1436 (Sales)
​
​​
​
​
​